Broder M, Quock T, Chang E, Reddy S, Agarwal-Hashmi R, Arai S, et al. The Cost of Hematopoietic Stem-Cell Transplantation in the United States. Am Health Drug Benefits. 2017;10:366–74.

Marziarz R, Gergis U, Edwards M, Song Y, Liu Q, Anderson A, et al. Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective. Blood Adv. 2024;8:1200–8.

Carerras E, Dufour C, Mohty M, Kroger N. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. Springer Nature; 2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553978/

Prabahran A, Koldej R, Chee L, Wong E, Ritchie D. Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation. Leuk Lymphoma. 2021;62:1482–9.

Article  CAS  PubMed  Google Scholar 

Muskens K, Lindemans C, Dandis R, Nierkens S, Belderbos M. Definitions, incidence and outcome of poor graft function after hematopoietic cell transplantation: A systematic review and meta-analysis. Blood Rev. 2023;60:101076.

Article  PubMed  Google Scholar 

Prabahran A, Koldej R, Chee L, Ritchie D. Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation. Blood Adv. 2022;6:1947–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nampoothiri RV, Ho L, McEwan C, Pasic I, Lam W, Law AD, et al. Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation. Bone Marrow Transpl. 2021;56:2471–6.

Article  CAS  Google Scholar 

Yuan C, Boyd AM, Nelson J, Patel RD, Varela JC, Goldstein SC, et al. Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transpl. 2019;25:1320–4.

Article  CAS  Google Scholar 

Peffault de Latour R, Chevret S, Ruggeri A, Suarez F, Souchet L, Michonneau D, et al. Romiplostim in patients undergoing hematopoietic stem cell transplantation: results of a phase 1/2 multicenter trial. Blood. 2020;135:227–9.

Article  PubMed  Google Scholar 

Shahzad M, Siddiqui RS, Anwar I, Chaudhary SG, Ali T, Nassem M, et al. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Transpl Cell Ther. 2021;27:877.e1–877.e8.

Article  CAS  Google Scholar 

Gaffet M, Wiedemann A, Dalle JH, Bilger K, Forcade E, Robin M, et al. Efficacy of haematopoietic stem cell boost as a rescue for poor graft function after haematopoietic stem cell transplantation: A multicentre retrospective study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Br J Haematol. 2023;201:1153–8.

Article  CAS  PubMed  Google Scholar 

Kong Y, Wang Y, Zhang Y, Shi M, Mo X, Sun Y, et al. Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation. Blood Adv. 2019;3:1303–17.

Article  CAS  PubMed  PubMed Central  Google Scholar